title: LDL apheresis with dextran sulfate and angiotension receptor antagonist (Losartan).
abstract: Anaphylactoid reactions during low-density lipoprotein (LDL) apheresis with dextran sulphate adsorption have been reported in patients taking angiotensin converting enzyme (ACE) inhibitors.
authors.affiliation: LDL Apheresis Unit, Department of Internal Medicine, University of Genoa, Italy.
authors.forename: N
authors.initials: N
authors.lastname: Elicio
authors.forename: S
authors.initials: S
authors.lastname: Bertolini
authors.forename: R
authors.initials: R
authors.lastname: Garbarini
authors.forename: G
authors.initials: G
authors.lastname: Nardiello
authors.forename: A
authors.initials: A
authors.lastname: Elicio
authors.forename: V
authors.initials: V
authors.lastname: Aimale
mesh_terms: D000707:Anaphylaxis / Q000188:drug therapy / Q000209:etiology; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000818:Animals; D000925:Anticoagulants / Q000378:metabolism; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D001781:Blood Component Removal / Q000009:adverse effects*; D001794:Blood Pressure / Q000187:drug effects; D016264:Dextran Sulfate / Q000378:metabolism; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008077:Lipoproteins, LDL / Q000097:blood / Q000302:isolation & purification*; D019808:Losartan; D013777:Tetrazoles / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000925:Anticoagulants; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D007093:Imidazoles; D008077:Lipoproteins, LDL; D013777:Tetrazoles; D016264:Dextran Sulfate; D019808:Losartan